Nobuhiro Nishii

Medicine & Life Sciences

1. Brugada Syndrome 100%
2. Ventricular Fibrillation 53%
3. Implantable Defibrillators 40%
4. Heart Failure 26%
5. Electrocardiography 24%
6. Lead 23%
7. Cardiac Resynchronization Therapy 21%
8. Equipment and Supplies 20%
9. Ventricular Tachycardia 19%
10. Cardiac Arrhythmias 17%
11. Defibrillators 17%
12. Japan 14%
13. Tachycardia 13%
14. Registries 13%
15. Syncope 13%
16. 1,5-anhydro-1-(5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl)-1-thioglucitol 12%
17. Electric Impedance 11%
18. Atrial Fibrillation 10%
19. Sarcoidosis 10%
20. Primary Prevention 10%
21. Sodium Channel Blockers 9%
22. Bundle-Branch Block 9%
23. voglibose 8%
24. Hypertrophic Cardiomyopathy 8%
25. Hospitalization 8%
26. Ventricular Premature Complexes 7%
27. pilsicainide 7%
28. Catheter Ablation 7%
29. Brain Natriuretic Peptide 7%
30. Mutation 7%
31. Cardiac Resynchronization Therapy Devices 7%
32. Sudden Cardiac Death 7%
33. Dilated Cardiomyopathy 6%
34. Long QT Syndrome 6%
35. Heart Ventricles 6%
36. 4-hydroxy-2-nonenal 6%
37. Shock 6%
38. Torsades de Pointes 5%
39. Fontan Procedure 5%
40. Databases 5%
41. Atrial Heart Septal Defects 5%
42. Therapeutics 5%
43. Coronary Artery Disease 5%
44. Stroke Volume 5%
45. Oxidative Stress 5%
46. alternan 5%
47. Pulmonary Arterial Hypertension 5%
48. Hemodynamics 5%